Prostate Cancer Subtype that Responds to Immunotherapy Identified

(MedPage Today) -- CDK12 variants make tumors vulnerable to immune checkpoint inhibitors
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news